日本毒性学会学術年会
第41回日本毒性学会学術年会
セッションID: P-44
会議情報

優秀研究発表 ポスター
ナノ酸化亜鉛が、ブレオマイシンによって誘導されるマウスの肺線維症に与える影響
*呉 文亭市原 学及川(多田) 佐枝子鈴木 悠加常 杰橋本 直純長谷川 好規Corina GABAZZAEsteban GABAZZA市原 佐保子
著者情報
会議録・要旨集 フリー

詳細
抄録
The present study investigated effects of exposure to ZnO nanoparticles on pulmonary fibrosis in a mouse model treated with bleomycin (BLM). Female C57BL/6Jcl mice were divided into BLM and non-BLM groups. In each group, three doses (10, 20, 30 µg/mouse) of ZnO nanoparticles with primary diameter of 20 nm were delivered into the lungs through pharyngeal aspiration. Bronchoalveolar lavage fluid (BALF) and the lungs were collected at 10 or 14 days after administration. Exposure to ZnO nanoparticles dose-dependently decreased the body weight and increased the lung weight.
At 10 days after administration, the counts of total cell, neutrophil and lymphocyte in BALF increased in both BLM and non-BLM groups. The levels of IL-1 beta and MCP-1 in BALF also increased in BLM groups, while no significant change was observed in non-BLM groups. Moreover, the levels of such inflammatory cytokines were much higher in BLM groups than those in non-BLM groups. With regard to pathological changes, in contrast to the recovered inflammatory infiltration in non-BLM groups, collagen deposition was observed in BLM groups exposed to 20 µg ZnO nanoparticles at 14 days post administration.
This study showed that exposure to ZnO nanoparticles induced pulmonary inflammation to a larger extent in the BLM-treated mice than the BLM-non-treated mice. The study suggests that BLM-treated mice give a sensitive model for investigation on the profibrotic effects of pulmonary exposure to engineered nanomaterials.
著者関連情報
© 2014 日本毒性学会
前の記事 次の記事
feedback
Top